Stockscreener 앱 받기
2.57
1.91%
-0.05
전일 마감가:
$2.62
열려 있는:
$2.57
하루 거래량:
6.09M
Relative Volume:
0.68
시가총액:
$1.07B
수익:
$1.70B
순이익/손실:
$-123.70M
주가수익비율:
-9.6508
EPS:
-0.2663
순현금흐름:
$-178.21M
1주 성능:
+16.29%
1개월 성능:
-14.33%
6개월 성능:
-42.38%
1년 성능:
+2.39%
1일 변동 폭
$2.51
$2.625
1주일 범위
$2.12
$2.67
52주 변동 폭
$2.12
$4.87
Clover Health Investments Corp Stock (CLOV) Company Profile
명칭
Clover Health Investments Corp
전화
(201) 432-2133
주소
30 MONTGOMERY STREET, JERSEY CITY
CLOV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CLOV
Clover Health Investments Corp
|
2.57 | 1.34B | 1.70B | -123.70M | -178.21M | -0.2663 |
|
UNH
Unitedhealth Group Inc
|
271.49 | 246.17B | 422.82B | 22.09B | 25.27B | 23.08 |
|
CVS
Cvs Health Corp
|
66.73 | 83.58B | 386.46B | 4.49B | 4.78B | 3.58 |
|
CI
Cigna Group
|
290.35 | 76.64B | 261.22B | 5.40B | 3.94B | 18.32 |
|
ELV
Elevance Health Inc
|
295.43 | 66.30B | 189.25B | 5.35B | 5.34B | 23.50 |
|
HUM
Humana Inc
|
281.34 | 33.92B | 117.76B | 1.21B | 2.39B | 9.95 |
Clover Health Investments Corp Stock (CLOV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-17 | 개시 | Craig Hallum | Buy |
| 2024-10-07 | 개시 | UBS | Neutral |
| 2022-02-02 | 개시 | Canaccord Genuity | Buy |
| 2022-02-02 | 업그레이드 | Cowen | Underperform → Market Perform |
| 2022-01-19 | 개시 | SVB Leerink | Mkt Perform |
| 2022-01-10 | 재개 | Citigroup | Neutral |
| 2022-01-07 | 다운그레이드 | Credit Suisse | Neutral → Underperform |
| 2021-09-10 | 개시 | Cowen | Underperform |
| 2021-09-02 | 재개 | Citigroup | Neutral |
| 2021-07-12 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2021-06-10 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2021-05-17 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2021-03-09 | 개시 | Credit Suisse | Neutral |
| 2021-02-02 | 개시 | Citigroup | Buy |
| 2021-02-01 | 개시 | JP Morgan | Neutral |
모두보기
Clover Health Investments Corp 주식(CLOV)의 최신 뉴스
Loengard Anna U buys Clover Health investments (CLOV) shares By Investing.com - Investing.com
Clover Health, Surgery Partners, Illumina, Bruker, and Supernus Pharmaceuticals Shares Skyrocket, What You Need To Know - ca.finance.yahoo.com
Clover Health rises after former CEO buys shares - MSN
Clover Health Addresses Shareholder Concerns with FAQ Release - AInvest
Healthcare AI Market Explodes 38.5% Annually as Diagnostics Gain FDA Traction - The Globe and Mail
Clover Health at Canaccord Conference: Strategic Tech-Driven Growth - Investing.com
Clover Health Investments : August 2025 Investor Presentation - MarketScreener
Clover Health Engages Shareholders with FAQ Release - TipRanks
Clover Health Set To Join Russell 3000® Index - Barchart.com
Insider Buying at Clover Health: A Signal of Value or Short-Term Confidence? - AInvest
Clover Health rises after former CEO buys shares (CLOV) - Seeking Alpha
Clover Health: Short-Term Pain Hides Its Long-Term Profitability Potential (NASDAQ:CLOV) - Seeking Alpha
Clover Health Stock (CLOV): Insider Confidence Sparks Rally - Value The Markets
Co-Founder & Executive Chairman of Clover Health Investments Vivek Garipalli Buys 32% More Shares - simplywall.st
Clover Health Investments Maintains Hold Rating from Leerink Partners, Price Target at $2.50 - AInvest
Clover drops despite Q2 beat amid concerns over medical cost trends - MSN
CLOVER HEALTH INVESTMENTS, CORP. /DE SEC 10-Q Report - TradingView
Clover Health Earnings Call: Growth and Profitability Insights - The Globe and Mail
Clover Health Investments, Corp. (NASDAQ:CLOV) Q2 2025 Earnings Call Transcript - Insider Monkey
Clover Health Investments Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Clover Health shares rise 1.33% premarket after 2Q25 earnings call and UBS price target adjustment. - AInvest
Clover Health CEO Reynoso sells $19,718 in shares By Investing.com - Investing.com Canada
Clover Health CEO Reynoso sells $19,718 in shares - Investing.com India
Clover Health Reports Strong Q2 2025 Growth - The Globe and Mail
Clover Health Investments, Corp. (CLOV) Q2 Earnings Meet Estimates - MSN
Clover Health stock drops on Q2 report release - Nashville Post
Clover stock drops despite Q2 beat (CLOV:NASDAQ) - Seeking Alpha
CLOV Q2 Earnings In Line, Stock Falls on Raised Insurance BER View - TradingView
UBS Adjusts Price Target on Clover Health Investments to $3 From $4.50, Maintains Neutral Rating - MarketScreener
Community Health Systems, Inc. shares fall 1.61% premarket after Clover Health reports Q2 loss. - AInvest
Clover Health shares fall 11.58% premarket after reporting a Q2 loss of $10.58 million. - AInvest
Clover Health Investments Corp (CLOV) Q2 2025 Earnings Call Highlights: Surpassing Growth ... - Yahoo Finance
Clover Health Investments Corp (CLOV) Q2 2025 Earnings Call High - GuruFocus
Clover Health (CLOV) Q2 Sales Up 34% - AOL.com
Clover Health Investments Q2 2025 Earnings Call Transcript - AInvest
Clover Health Investments earnings beat by $0.05, revenue topped estimates By Investing.com - Investing.com South Africa
Clover Health Posts Rising Revenue And Beats Profit Targets - Finimize
Earnings call transcript: Clover Health Q2 2025 sees revenue beat, stock dips - Investing.com
Clover Beats Q2 Estimates, Stock Drops: Here Are The Details - 富途牛牛
Clover Health (NASDAQ:CLOV) Beats Q2 Sales Targets But Stock Drops - Yahoo Finance
Clover Health Investments Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Clover Health Q2 revenue beats expectations - MarketScreener
Clover Health Q2 2025 slides: 32% membership growth amid sustained profitability - Investing.com Nigeria
Earnings Flash (CLOV) Clover Health Investments, Corp. Reports Q2 Revenue $477.6M, vs. FactSet Est of $468.3M - MarketScreener
Clover Health Reports Second Quarter 2025 Results; Delivering Strong Sustainable Growth - The Manila Times
RENEW 8-K: Ninth SPAC Extension Adds $250k to Trust, Deadline Sep 5 2025 | CLOV SEC FilingForm 8-K - Stock Titan
Clover Health Investments Corp (CLOV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.21%
0.41%
자본화:
|
볼륨(24시간):